Cardiovascular Risk Screening in Boca Raton
Your Cholesterol Panel Is a Starting Point. Not an Answer
Total cholesterol. LDL. HDL. Triglycerides. Your doctor glances at the numbers, says everything looks fine, and moves on. But those four numbers don’t tell you what actually drives cardiovascular risk. Two people with identical LDL can face dramatically different cardiac outcomes — because particle size, particle count, inflammation, and arterial wall function matter far more than the number on your lab report.
Heart disease is still the leading cause of death in the United States. A significant portion of people who experience their first cardiac event had cholesterol numbers their physician considered acceptable. The gap between what a standard panel measures and what actually predicts risk is wide enough to matter — and wide enough to close, for patients with access to advanced screening.
Advanced Cardiovascular Assessment at BRCM
Dr. Jeffrey Stein’s approach reflects 34 years of clinical practice and a commitment to evidence that goes beyond the default standard of care. For concierge members in Boca Raton, that means comprehensive assessment — the markers and tests that high-performing cardiovascular medicine has validated as predictive, not just what insurance typically covers.
Lipid Fractionation and Particle Analysis
LDL particle number and size are more predictive of cardiac events than LDL-C alone. Small, dense particles penetrate arterial walls more readily than large, buoyant ones. Two patients with identical LDL-C values can have substantially different risk profiles. Dr. Stein orders fractionated lipid testing where the clinical picture warrants it — giving you a far more accurate picture than a standard panel ever could.
Inflammatory Markers
Chronic low-grade inflammation is a central driver of atherosclerosis. High-sensitivity CRP and, where indicated, Lp-PLA2 provide information about vascular inflammation that lipid numbers alone cannot. Elevated inflammatory markers in the context of otherwise acceptable lipids still represent real risk — risk that benefits from targeted intervention.
Lipoprotein(a)
Lp(a) is genetically determined, significantly elevates cardiovascular and aortic valve disease risk, is not measured by standard lipid panels, does not respond to statin therapy, and most patients have never had it checked. For anyone with a family history of early cardiovascular disease or unexplained cardiac events, Lp(a) testing is essential.
Metabolic and Glycemic Markers
Insulin resistance often precedes overt diabetes by years — and carries independent cardiovascular risk. Fasting insulin, hemoglobin A1c, and a detailed metabolic panel can identify early metabolic dysfunction in patients whose glucose still looks normal. That window is exactly when intervention makes the biggest difference.
Coronary Artery Calcium Scoring
For members who meet appropriate criteria, Dr. Stein coordinates access to CAC scoring — a low-radiation CT scan that directly measures calcified plaque in the coronary arteries and provides one of the strongest available predictors of cardiovascular events. Particularly valuable for intermediate-risk patients where standard guidelines offer the least guidance.
Coordinated, Continuous Care
When Dr. Stein identifies elevated cardiovascular risk, he doesn’t simply refer out and step back. His 34-year referral network in Boca Raton and greater South Florida includes cardiologists, imaging centers, and interventional specialists he trusts personally. He coordinates that care, reviews the findings with you directly, and integrates results into your ongoing health plan. That continuity is precisely what cardiovascular risk management requires.